Clinical Trials Browser

Phase 1/2 × Lymphoma × penpulimab × Clear all

NCT05400876 2023-02-14

To Evaluate the Safety and Efficacy of TQB2618 Injection Combined With Penpulimab in the Treatment of Patients With Relapsed and Refractory Lymphoma

Phase 1/2 Unknown

Lymphoma